GNCA logo

Genocea Biosciences (GNCA) Cash From Investing

Annual CFI

-$3.21 M
-$653.00 K-25.56%

December 31, 2021

Summary

Performance

1-Year Change

-25.56%

3-Year Change

-2348.85%

5-Year Change

-109.19%

15-Year Change

-109.19%

GNCA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.71 M
GNCA annual cash flow from investing activities is currently -106.33% below its historical high of $50.71 million

3-Year Low

-$3.21 M
GNCA annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
GNCA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
GNCA next annual earnings announcement has not yet been scheduled

OtherGNCAcash flowmetrics:

Annual CFF

$5.96 M
GNCA annual cash flow from financing activities is $5.96 million

Annual CFO

-$45.37 M
GNCA annual cash flow from operations is -$45.37 million

Annual FCF

-$48.66 M
GNCA annual free cash flow is -$48.66 million

Annual CAPEX

$3.29 M
GNCA annual capital expenditures is $3.29 million

Quarterly CFI

-$939.00 K
-$19.00 K-2.07%

March 31, 2022

Summary

Performance

3-Month Change

-2.07%

1-Year Change

+10.06%

3-Year Change

-324.89%

5-Year Change

-104.45%

GNCA Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$30.64 M
GNCA quarterly cash flow from investing activities is currently -103.06% below its historical high of $30.64 million

3-Year Low

-$939.00 K
GNCA quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
GNCA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
GNCA next earnings announcement has not yet been scheduled

OtherGNCAcash flowmetrics:

Quarterly CFF

-$863.00 K
GNCA quarterly cash flow from financing activities is -$863.00 thousand

Quarterly CFO

-$15.21 M
GNCA quarterly cash flow from operations is -$15.21 million

Quarterly FCF

-$16.17 M
GNCA quarterly free cash flow is -$16.17 million

Quarterly CAPEX

$961.00 K
GNCA quarterly capital expenditures is $961.00 thousand

TTM CFI

-$3.10 M
+$105.00 K+3.27%

March 31, 2022

Summary

Performance

3-Month Change

+3.27%

1-Year Change

+8.25%

3-Year Change

-185.46%

5-Year Change

-185.46%

GNCA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$66.01 M
GNCA TTM cash flow from investing activities is currently -104.70% below its historical high of $66.01 million

3-Year Low

-$3.21 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
GNCA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
GNCA next earnings announcement has not yet been scheduled

OtherGNCAcash flowmetrics:

TTM CFF

$5.39 M
GNCA TTM cash flow from financing activities is $5.39 million

TTM CFO

-$48.19 M
GNCA TTM cash flow from operations is -$48.19 million

TTM FCF

-$51.33 M
GNCA TTM free cash flow is -$51.33 million

TTM CAPEX

$3.14 M
GNCA TTM capital expenditures is $3.14 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GNCA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.6%+10.1%+8.3%
3 y3 years-2348.8%-324.9%-185.5%
5 y5 years-109.2%-104.5%-185.5%

GNCA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+2.1%at lowat high+3.4%
5 y5-year+195.1%at low+702.6%+45.6%+216.6%+22.0%
alltimeall time-106.3%+1924.2%-103.1%+4751.3%-104.7%+1992.7%

Genocea Biosciences Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2022
-
-$939.00 K(+2.1%)
-$3.10 M(-3.3%)
Dec 2021
-$3.21 M(+25.6%)
-$920.00 K(+73.6%)
-$3.21 M(-12.2%)
Sep 2021
-
-$530.00 K(-25.8%)
-$3.65 M(-3.4%)
Jun 2021
-
-$714.00 K(-31.6%)
-$3.79 M(+11.9%)
Mar 2021
-
-$1.04 M(-23.6%)
-$3.38 M(+32.4%)
Dec 2020
-$2.56 M(+135.1%)
-$1.37 M(+107.1%)
-$2.56 M(+95.8%)
Sep 2020
-
-$660.00 K(+112.2%)
-$1.30 M(+33.2%)
Jun 2020
-
-$311.00 K(+43.3%)
-$980.00 K(-9.5%)
Mar 2020
-
-$217.00 K(+85.5%)
-$1.08 M(-0.4%)
Dec 2019
-$1.09 M(+729.8%)
-$117.00 K(-65.1%)
-$1.09 M(+13.2%)
Sep 2019
-
-$335.00 K(-19.1%)
-$960.00 K(+44.6%)
Jun 2019
-
-$414.00 K(+87.3%)
-$664.00 K(+62.7%)
Mar 2019
-
-$221.00 K(-2310.0%)
-$408.00 K(+211.5%)
Dec 2018
-$131.00 K(-100.4%)
$10.00 K(-125.6%)
-$131.00 K(-263.8%)
Sep 2018
-
-$39.00 K(-75.3%)
$80.00 K(-120.3%)
Jun 2018
-
-$158.00 K(-382.1%)
-$394.00 K(-102.8%)
Mar 2018
-
$56.00 K(-74.7%)
$13.85 M(-60.3%)
Dec 2017
$34.91 M
$221.00 K(-143.1%)
$34.91 M(-26.1%)
Sep 2017
-
-$513.00 K(-103.6%)
$47.23 M(-28.4%)
DateAnnualQuarterlyTTM
Jun 2017
-
$14.09 M(-33.3%)
$66.01 M(+60.3%)
Mar 2017
-
$21.11 M(+68.3%)
$41.18 M(-18.8%)
Dec 2016
$50.71 M(-178.1%)
$12.54 M(-31.3%)
$50.71 M(+185.2%)
Sep 2016
-
$18.26 M(-270.1%)
$17.78 M(-138.6%)
Jun 2016
-
-$10.74 M(-135.0%)
-$46.04 M(+35.2%)
Mar 2016
-
$30.64 M(-250.3%)
-$34.06 M(-47.5%)
Dec 2015
-$64.94 M(+127.3%)
-$20.39 M(-55.2%)
-$64.94 M(+44.9%)
Sep 2015
-
-$45.55 M(-3776.7%)
-$44.83 M(>+9900.0%)
Jun 2015
-
$1.24 M(-634.1%)
-$311.00 K(-98.9%)
Mar 2015
-
-$232.00 K(-18.0%)
-$28.78 M(+0.7%)
Dec 2014
-$28.57 M(+7245.2%)
-$283.00 K(-72.7%)
-$28.57 M(+1.0%)
Sep 2014
-
-$1.03 M(-96.2%)
-$28.29 M(+3.6%)
Jun 2014
-
-$27.23 M(>+9900.0%)
-$27.30 M(>+9900.0%)
Mar 2014
-
-$27.00 K(+800.0%)
-$81.00 K(-79.2%)
Dec 2013
-$389.00 K(-15.4%)
-$3000.00(-93.2%)
-$389.00 K(+0.8%)
Sep 2013
-
-$44.00 K(+528.6%)
-$386.00 K(+12.9%)
Jun 2013
-
-$7000.00(-97.9%)
-$342.00 K(+2.1%)
Mar 2013
-
-$335.00 K
-$335.00 K
Dec 2012
-$460.00 K(+44.7%)
-
-
Dec 2011
-$318.00 K
-
-

FAQ

  • What is Genocea Biosciences annual cash flow from investing activities?
  • What is the all time high annual CFI for Genocea Biosciences?
  • What is Genocea Biosciences annual CFI year-on-year change?
  • What is Genocea Biosciences quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Genocea Biosciences?
  • What is Genocea Biosciences quarterly CFI year-on-year change?
  • What is Genocea Biosciences TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Genocea Biosciences?
  • What is Genocea Biosciences TTM CFI year-on-year change?

What is Genocea Biosciences annual cash flow from investing activities?

The current annual CFI of GNCA is -$3.21 M

What is the all time high annual CFI for Genocea Biosciences?

Genocea Biosciences all-time high annual cash flow from investing activities is $50.71 M

What is Genocea Biosciences annual CFI year-on-year change?

Over the past year, GNCA annual cash flow from investing activities has changed by -$653.00 K (-25.56%)

What is Genocea Biosciences quarterly cash flow from investing activities?

The current quarterly CFI of GNCA is -$939.00 K

What is the all time high quarterly CFI for Genocea Biosciences?

Genocea Biosciences all-time high quarterly cash flow from investing activities is $30.64 M

What is Genocea Biosciences quarterly CFI year-on-year change?

Over the past year, GNCA quarterly cash flow from investing activities has changed by +$105.00 K (+10.06%)

What is Genocea Biosciences TTM cash flow from investing activities?

The current TTM CFI of GNCA is -$3.10 M

What is the all time high TTM CFI for Genocea Biosciences?

Genocea Biosciences all-time high TTM cash flow from investing activities is $66.01 M

What is Genocea Biosciences TTM CFI year-on-year change?

Over the past year, GNCA TTM cash flow from investing activities has changed by +$279.00 K (+8.25%)